Translating medical discoveries into patient care is a difficult task everywhere – but there are several obstacles to success in Europe. This roundtable discussion, bringing together leaders in European research, industry and policy for healthcare, will identify some of the key problems – and discuss solutions relevant to the new Parliament and Commission. At stake is the health of millions of Europeans who will be needing new treatments, and an industry on which thousands of jobs rely.
12:00 - Doors open, registration & networking lunch
13:00 - Welcome by:
- Jacqueline Kay Swinburne, Member, European Parliament
- Richard Hudson, CEO and Editor, Science|Business
13:10 - Keynote and Q&A
- Anne Glover, Chief Scientific Advisor to the President, European Commission
13:40 - The Healthcare Biotech Value Chain: Upstream – What challenges for discovery, research and production?
- Anne Glover, Chief Scientific Advisor to the President, European Commission
- Maria Pilar Aguar Fernandez, Head of Unit Chemical Assessment and Testing, Joint Research Centre, European Commission
- Philippe de Backer, Member, European Parliament
- Sylvie Bove, Head of Life Sciences, Medicon Valley
- Thomas Saylor, CEO, Arecor
14:40 - Coffee
15:10 - The Healthcare Biotech Value Chain: Downstream – How best to reach the patients?
- Jacqueline Kay Swinburne, Member, European Parliament
- Bernd Reichert, Head of Unit, European Agency for Small and Medium Enterprises, European Commission
- John Davis, Head of Division, Life Sciences and Health, European Investment Bank
- Alastair Kent, Genetic Alliance UK
- Emmanuel Chantelot, Chair of EuropaBio Healthcare Council
16:15 - Close
Partners
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
